Editas Medicine Inc (EDIT)
NASDAQ:EDIT
Total Valuation
Editas Medicine has a market cap or net worth of $234.89M. The enterprise value is $164.95M.
Market Cap$234.89M
Enterprise Value$164.95M
Share Statistics
Editas Medicine has 97,872,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding97,872,000
Owned by Insiders0.54%
Owned by Institutions3.66%
Financial Efficiency
Editas Medicine’s return on equity (ROE) is -5.87 and return on invested capital (ROIC) is -65.65%.
Return on Equity (ROE)-5.87
Return on Assets (ROA)-0.86
Return on Invested Capital (ROIC)-65.65%
Return on Capital Employed (ROCE)-0.71
Revenue Per Employee164.72K
Profits Per Employee-650.65K
Employee Count246
Asset Turnover0.22
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Editas Medicine is ―. Editas Medicine’s PEG ratio is 0.03.
PE Ratio―
PS Ratio4.49
PB Ratio6.67
Price to Fair Value6.67
Price to FCF-1.10
Price to Operating Cash Flow-1.29
PEG Ratio0.03
Income Statement
In the last 12 months, Editas Medicine had revenue of 40.52M and earned -160.06M in profits. Earnings per share was -1.80.
Revenue40.52M
Gross Profit35.24M
Operating Income-99.34M
Pretax Income-160.06M
Net Income-160.06M
EBITDA-94.06M
Earnings Per Share (EPS)-1.80
Cash Flow
In the last 12 months, operating cash flow was -165.24M and capital expenditures -607.00K, giving a free cash flow of -165.85M billion.
Operating Cash Flow-165.24M
Free Cash Flow-165.85M
Free Cash Flow per Share-1.69
Dividends & Yields
Editas Medicine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.98
52-Week Price Change84.62%
50-Day Moving Average2.10
200-Day Moving Average2.57
Relative Strength Index (RSI)56.11
Average Volume (3m)1.70M
Important Dates
Editas Medicine upcoming earnings date is May 6, 2026, TBA (Confirmed).
Last Earnings DateMar 9, 2026
Next Earnings DateMay 6, 2026
Ex-Dividend Date―
Financial Position
Editas Medicine as a current ratio of 3.54, with Debt / Equity ratio of 281.10%
Current Ratio3.54
Quick Ratio3.54
Debt to Market Cap0.36
Net Debt to EBITDA0.74
Interest Coverage Ratio-16.10
Taxes
In the past 12 months, Editas Medicine has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Editas Medicine EV to EBITDA ratio is -1.19, with an EV/FCF ratio of -0.68.
EV to Sales2.76
EV to EBITDA-1.19
EV to Free Cash Flow-0.68
EV to Operating Cash Flow-0.68
Balance Sheet
Editas Medicine has $146.65M in cash and marketable securities with $76.71M in debt, giving a net cash position of $69.94M billion.
Cash & Marketable Securities$146.65M
Total Debt$76.71M
Net Cash$69.94M
Net Cash Per Share$0.71
Tangible Book Value Per Share$0.31
Margins
Gross margin is 98.01%, with operating margin of -245.15%, and net profit margin of -395.01%.
Gross Margin98.01%
Operating Margin-245.15%
Pretax Margin-395.01%
Net Profit Margin-395.01%
EBITDA Margin-232.13%
EBIT Margin-245.15%
Analyst Forecast
The average price target for Editas Medicine is $5.15, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$5.15
Price Target Upside114.58% Upside
Analyst ConsensusHold
Analyst Count8
Revenue Growth Forecast-24.90%
EPS Growth Forecast7.19%